Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Latest filing published 03 Jul 2025 for Kezar Life Sciences, Inc., €2,035. Read the official filing
Filing timeline
BuySaleMark C. Schiller
Insider track record
Disclosed buys
0
Disclosed sells
2
Signal history
Mark C. Schiller: trading record in brief
Mark C. Schiller is a declared insider of Kezar Life Sciences, Inc., with filings sourced from SEC (Form 4). In total, 2 filings cover trades dated from 2 July 2024 to 2 July 2025.
Sales make up the whole of the open-market record (2 sales, €5,644). Since January 2025: no purchases and 1 sale on the market.
Most recently, on 3 July 2025, the filings show an open-market sale worth €2,035 in Kezar Life Sciences, Inc. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Mark C. Schiller
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
561 shares@ US$4.2836.1% of flowCommon StockSEC:0001415889-25-019310:0
6,688 shares@ US$0.5863.9% of flowCommon StockSEC:0001415889-24-020202:0
2 of 2 declarations
